Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE from Sint-Truiden, company number BE0715841192, closed financial year 2025 with a result of € 0 after tax. For that financial year NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE recorded a gross margin of € 565,914 and equity of € 20,000. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 20,000
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 10,248
▼ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
People and assets in 2025
6.1
Average over the fiscal year, from the social balance sheet.
€ 546,738
▼ 11% vs 2024
€ 89,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,328
▼ 33% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 44,463
▼ 19% vs 2024
€ 10,962 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 47,718
▼ 3% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 95,166
▼ 4% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 522,846 | € 623,895 | € 634,167 | € 565,914 | ▼ 11% |
| Equity | € 20,000 | € 20,000 | € 20,000 | € 20,000 | |
| Total debts | € 673,771 | € 719,110 | € 679,447 | € 726,896 | ▲ 7% |
| Cash | € 20,880 | € 31,143 | € 37,199 | € 10,248 | ▼ 72% |
| Land & buildings | € 70,022 | € 59,949 | € 49,876 | € 39,804 | ▼ 20% |
| Bank debt | € 75,827 | € 65,620 | € 55,167 | € 44,463 | ▼ 19% |
| Balance sheet total | € 693,771 | € 739,110 | € 699,447 | € 746,896 | ▲ 7% |
| Employees (FTE) | 6.2 | 6.2 | 6.1 | 6.1 |
Key figures of NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE?
What happened at NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- J. Goyens & A. Vanhee - Neurologie BV stepped down as director. NBB
- Dokters Darcis-Vanbilsen BV became a director. NBB
- Annabel Schreurs became a director. NBB
- Dokter Tine Breban BV became a director. NBB
- Dr. S. Verjans BV became a director. NBB
- Dr. De Vooght - Dr. Delahaye BV became a director. NBB
- Dr. Hendrix Sam BV became a director. NBB
In short
From € 0 profit in 2022 to € 0 profit in 2025.
Paid € 844 in corporate taxes since 2022.
On average € 92,800 of value added per employee in 2025.
A new publication or filing at NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE? We notify you, reason included.
Follow NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DOKTER TINE BREBAN, Dr. De Vooght-Dr. Delahaye comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIEBehind NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE are Dokters Darcis-Vanbilsen BV, Annabel Schreurs, Dokter Tine Breban BV, Dr. S. Verjans BV, Dr. De Vooght - Dr. Delahaye BV and Dr. Hendrix Sam BV. The shares are held by DOKTER TINE BREBAN (12.5%) and Dr. De Vooght-Dr. Delahaye (12.5%).
Directors
According to the 2025 annual accounts
Director · represented by Johan Darcis
since 2023
Annabel Schreurs
Director
since 2023
Director · represented by Tine Breban
since 2023
Director · represented by Sarah Verjans
since 2023
Dr. De Vooght - Dr. Delahaye BV
Director · represented by Wouter De Vooght
since 2023
Director · represented by Sam Hendrix
since 2023
Director · represented by Liesbet Van Mol
since 2023
J. Goyens & A. Vanhee - Neurologie BV
Director · represented by Jo Goyens
since 2023 · until 2025
Shareholders
12.5%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Diestersteenweg 100
3800 Sint-Truiden
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →Nierpatiëntenvereniging-Sint-Truiden
VERENIGING MEDISCHE STAF H. FAMILIEZIEKENHUIS
Regionaal Ziekenhuis Heilige Familie
Sint-Trudo Ziekenhuis
€ 181.3 million revenue · 2025
Nefrologie Sint Trudo Ziekenhuis
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0715.841.192
- VAT number
- BE 0715.841.192
- Registered office
- Diestersteenweg 100, 3800 Sint-Truiden
- Names & denominations
- NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 December 2018
- Peppol
- Active · Active since 1 Oct 2024
- Contact
- sint-trudo.be
- Activities · NACE
Activiteiten van medisch specialisten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied